Skip to main content

Ixempra Disease Interactions

There are 4 disease interactions with Ixempra (ixabepilone).

Major

Ixabepilone (applies to Ixempra) cytopenia

Major Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopenia, Neutropenia, Immunodeficiency

Ixabepilone is contraindicated in patients who have a neutrophil count <1500 cells/mm3 or a platelet count <100,000 cells/mm3.

References

  1. (2007) "Product Information. Ixempra (ixabepilone)." Bristol-Myers Squibb
Major

Ixabepilone (applies to Ixempra) liver dysfunction

Major Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Hyperbilirubinemia

The use of ixabepilone in combination with capecitabine is contraindicated in patients with AST or ALT >2.5 x ULN or bilirubin >1 x ULN due to increased risk of toxicity and neutropenia-related death.

References

  1. (2007) "Product Information. Ixempra (ixabepilone)." Bristol-Myers Squibb
Moderate

Ixabepilone (applies to Ixempra) cardiovascular

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Arrhythmias, Ischemic Heart Disease, Cardiovascular Disease

The use of ixabepilone in combination with capecitabine may increase cardiac adverse reactions, such as myocardial ischemia and ventricular dysfunction. Care should be exercised when using this agent in combination with capecitabine in patients with a history of cardiac disease. It is recommended to discontinue treatment in patients who develop cardiac ischemia or impaired cardiac function.

References

  1. (2007) "Product Information. Ixempra (ixabepilone)." Bristol-Myers Squibb
Moderate

Ixabepilone (applies to Ixempra) neuropathy

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Diabetes Mellitus, Peripheral Neuropathy

The use of ixabepilone in combination with capecitabine may cause peripheral neuropathy. Patients treated with ixabepilone in combination with capecitabine should be monitored for symptoms of neuropathy. Patients experiencing new or worsening symptoms may require a reduction or delay in the dose. Caution should be used when treating patients with diabetes mellitus or preexisting peripheral neuropathy.

References

  1. (2007) "Product Information. Ixempra (ixabepilone)." Bristol-Myers Squibb

Ixempra drug interactions

There are 399 drug interactions with Ixempra (ixabepilone).

Ixempra alcohol/food interactions

There is 1 alcohol/food interaction with Ixempra (ixabepilone).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer